<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
Current Report Pursuant
to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported) September 22, 2000
------------------
BIOZHEM COSMECEUTICALS, INC.
------------------------------------------------------
(Exact Name of Registrant as Specified in Its Charter)
Texas
----------------------------------------------
(State or Other Jurisdiction of Incorporation)
1-14725 76-0118305
------------------------ ------------------------------------
(Commission File Number) (I.R.S. Employer Identification No.)
32238 Paseo Adelanto Suite A San Juan Capistrano, CA. 92675
--------------------------------------------------------------------------------
(Address of Principal Executive Officers) (Zip Code)
(949) 488-2184
----------------------------------------------------
(Registrant's Telephone Number, Including Area Code)
---------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Reported)
Item 5. OTHER EVENTS
------------
On September 22, 2000, Biozhem Cosmeceuticals, Inc. ("Biozhem") entered
into an agreement with Beauty Resource, Inc. ("BRC") ,a Delaware Corporation, in
which BRC is engaged to provide certain designated BRC employees and consultants
to Biozhem for a period of five years. These individuals will perform management
services for Biozhem to include the responsibilities of the offices of the Chief
Executive Officer, Strategic and Business Development Officer, Director of
Retail Management and Director of Operations.
On September 22,2000 Biozhem signed a License and Supply Agreement with
Advanced Tissue Sciences, Inc., a Delaware Corporation ("ATS"), which gives
Biozhem the exclusive right to market skin care products containing ATS'
Nutrient Solution in the Direct Response market for a period of ten years
providing that sales goals are reached. Biozhem will also pay to ATS a royalty
and periodic milestone payments that are dependent on achieving certain annual
and cumulative sales levels.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Biozhem Cosmeceuticals, Inc.
September 22, 2000 By: /s/ JOHN C. RIEMANN
------------------ ---------------------------
John C. Riemann, Chairman
<PAGE>
BIOZHEM COSMECEUTICALS, INC., ANNOUNCES MANAGEMENT ADDITIONS
Biozhem Cosmeceuticals, Inc., (Biozhem), (OTC:BZHM) today announced that a
number of key management personnel had been brought into the Company. The newly
added executives have experience in all aspects of direct marketing.
Gayle Walker, the newly appointed CEO of Biozhem stated, "We have assembled a
very experienced, first-class management team with capabilities that encompass
all areas of the direct-response market. We joined Biozhem because we deeply
believe in the potential of the current and upcoming Biozhem products to
revolutionize the skincare industry."
Listed below are Biozhem's key executives. John Riemann, Marti Wolf and Kip
Yotter are Biozhem veterans. The others represent the newly appointed team.
JOHN RIEMANN, CHAIRMAN OF THE BOARD - Mr. Riemann has over 25 years of
successful entrepreneurial and executive management experience in the retail,
wholesale, distribution and franchising industries. His professional career
accomplishments include the assumption of equity and leadership positions in
turn-around situations where, through effective efforts, profitability was
achieved, operations were expanded and profitable exits were accomplished for
the companies and shareholders.
GAYLE WALKER, CEO - Ms. Walker has over 20 years experience in business
management, marketing and sales, in the industries of cosmetics and advanced
technology management consulting. From 1990-1996 she was President of Desert
Beauty Cosmetics, a skin care development and marketing company. She has
produced successful infomercial campaigns with celebrities such as Jill St.
John. Ms. Walker was responsible for bringing the first Glycolic Acid product
line using protolytic enzymes to market and produced the first infomercial to
showcase the new technology. Ms. Walker was actively involved in all phases of
production, product development, marketing direct mail campaigns, after-market
sales, budgets and forecasting. She began her career with the international
cosmetic company Helena Rubinstein.
MARTI WOLF, PRESIDENT - Ms. Wolf has extensive direct marketing and direct to
consumer sales experience. During her 28-year career in marketing that ranges
from the Fortune 100 to start-up companies, she has earned her reputation as an
expert in identifying and communicating the unique elements of a company,
product or service that sets it apart from the competition. Prior to joining
Biozhem, her most significant experience was as Executive Vice President of Kent
Spiegel, a leading national direct marketing concern. As head of one of their
largest divisions, she was responsible for seven $100+ million infomercial
rollouts.
JOSEPH VICTOR, DIRECTOR OF RETAIL MANAGEMENT - Mr. Victor is a recognized and
acknowledged expert in the field of health and beauty merchandising. He has over
30 years of experience in the cosmetics and fragrance retailing industry. As a
former CEO and Executive Vice President of Illinois Thrifty Drug, he was in
charge of the operations of over 70 retail outlets and managed over 650
employees.
ARNOLD SCHUCHTER, EVP STRATEGIC AND BUSINESS DEVELOPMENT - Mr. Schuchter spent
30 years in international consulting with ten years at Arthur D. Little, Inc.
His recent projects have included the design and implementation of a new drug
review process for the FDA, internet-based projects with Prime Meridian and
medical school management consulting with Indiana University, Duke, and Baylor
College of Medicine.
THOMAS MCGOVERN, DIRECTOR OF OPERATIONS - Mr. McGovern has more than 15 years
experience in executive management and operations. As a former CEO of five major
hospitals, Mr. McGovern has managed facilities of up to 4,000 employees, with
budgets from $10 - $40 million annually. He built successful management teams
and created programs that converted marginally profitable hospitals into the
leading healthcare facilities in their regions.
DENNIS HALL, DIRECTOR OF MEDIA AND MARKETING PRODUCTION - Mr. Hall previously
worked at Sigma-Aldrich, Inc., a world leader in the production, distribution
and sale of chemicals and equipment for biochemical research. He worked
concurrently on a contractual basis with Beauty Resource, Inc. to SAN JUAN
CAPISTRANO, Calif., September 25, 2000 /BUSINESS WIRE/ -- Biozhem Cosmeceuticals
Inc. (OTC BB: BZHM) today announced an agreement with Advanced Tissue Sciences,
Inc.(Nasgaq:ATIS) to bring the benefits of proprietary tissue engineering
technology to the retail marketplace. This License and Supply Agreement gives
Biozhem the exclusive right to market and sell skin care products containing
Advanced Tissue Sciences' nutrient solution in the direct response market
including infomercials and televised home shopping channels and also through the
Company's shopping mall-based skin care centers and kiosks. He worked
concurrently on a contractual basis with Beauty Resource, Inc. to develop
bilingual content, copy and graphics for its extensive productions for print and
infomercial media campaigns.
KIP YOTTER, CFO - Mr. Yotter has extensive experience with and background in all
phases of public company accounting. He has over 20 years of executive
management experience in the retail, direct marketing and distribution
industries.
Biozhem Cosmeceuticals, Inc. is a specialty retailer of premium quality
botanically based skin care for men and women. The company markets its products
through its retail Biozhem Skin Care Centers and kiosks as well as national
infomercials, catalogs and the Internet.
Statements about the company's future expectations and all other statements in
this news release other than historical facts are "forward-looking statements"
within the meaning of Section 27A of the Securities Act of 1933, Section 21E of
the Securities Exchange Act of 1934, and as that term is defined in the Private
Litigation Reform Act of 1995. The company intends that such forward-looking
statements be subject to the safe harbor created thereby. Since these statements
involve risks and uncertainties and are subject to change at any time, the
company's actual results could differ materially from expected results.
